Search clinical trials for: Neurokinin

Total 291 results

Zhuhai Beihai Biotech Co., Ltd

Not yet recruiting

An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Bioavailability
Montefiore Medical Center

Not yet recruiting

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting (AFTR NV RCT)

Nausea | Vomiting | Nausea and Vomiting

United States
IWK Health Centre

Not yet recruiting

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

Anesthesia | Spinal Fusion | Nausea and Vomiting, Postoperative
The Affiliated Hospital of Qingdao University

Not yet recruiting

Comparative Pharmacokinetic Study of Aprepitant Injection in Humans

Healthy
Hubei Cancer Hospital

Recruiting

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade

Nausea With Vomiting Chemotherapy-Induced

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Gynecological Tumor

China
Qilu Hospital of Shandong University

Not yet recruiting

Antiemetic Prophylaxis With Fosaprepitant and Ondansetron in Patients Undergoing Thoracic Surgery

Thoracic Diseases | Postoperative Nausea and Vomiting | Anesthesia Complication
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Breast Cancer | Chemotherapy-induced Nausea and Vomiting

China
Xijing Hospital

Recruiting

Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV. (COSEFDIP)

Neoplasms

China
Guangxi Medical University

Not yet recruiting

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Hepatocellular Carcinoma
Baskent University

Not yet recruiting

Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery (PONV)

Vomiting | Postoperative Nausea

Turkey
Federal Research Institute of Pediatric Hematology...

Recruiting

Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents (OZONE-V)

Chemotherapy-induced Nausea and Vomiting

Russian Federation
Shanghai Children's Medical Center

Not yet recruiting

Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs

Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Nausea | Vomiting | Head and Neck Squamous Cell Carcinoma | Radiotherapy Side Effect

China
University Hospital Inselspital, Berne

Recruiting

Dual-dose Aprepitant to Reduce Postoperative Nausea and Vomiting After Laparoscopic Bariatric Surgery. (DDA-PONV)

Postoperative Nausea and Vomiting | Bariatric Surgery

Switzerland
Fudan University

Not yet recruiting

Granisetron Transdermal Patch for Prophylaxis of Delayed CINV

Chemotherapy-induced Nausea and Vomiting (CINV)
Shanghai Children's Medical Center

Not yet recruiting

Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients

Chemotherapy Induced Nausea and Vomiting | Pediatric Cancer Patients

China
Yale University

Recruiting

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Heart Failure

United States
Jennifer Holder-Murray
Berry Consultants

Recruiting

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

Perioperative Optimization

United States
Vanda Pharmaceuticals

Recruiting

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Gastroparesis | Diabetic Gastroparesis | Idiopathic Gastroparesis

United States
University Hospital, Brest

Recruiting

Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms (APHYPAP)

Myeloproliferative Disorder | Aquagenic Pruritus

France
Rush University Medical Center

Completed

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Nausea | Vomiting

United States
National Cancer Institute (NCI)

Completed

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

NSCLC | Solid Tumors | Lymphomas | Granulosa Cell Ovarian Cancer | Metastatic Colon Carcinoma

United States
University of Edinburgh
NHS Lothian

Completed

Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)

Heart Disease | Vascular Disease

United Kingdom
Henan Cancer Hospital

Completed

Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

China
Vanda Pharmaceuticals
Mayo Clinic

Completed

Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers

Healthy Volunteer

United States
Xiao Jing (Iris) Wang
Mayo Clinic

Enrolling by invitation

Tradipitant for Functional Dyspepsia

Functional Dyspepsia

United States
Lahore Medical Research Center, LLP

Completed

Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea

Primary Dysmenorrhea

Pakistan
Vanderbilt University Medical Center

Active, not recruiting

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Hypertension

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Gynecologic Cancer

United States
Stony Brook University

Completed

Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy

Laparoscopic Sleeve Gastrectomy | Post-operative Nausea and Vomiting

United States
GlaxoSmithKline

Completed

Substance P Challenge in Healthy Participants

Skin Diseases

Netherlands
Shantou University Medical College

Completed

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Cervical Cancer | Nasopharyngeal Cancer | Chemotherapy-induced Nausea and Vomiting | Radiation-Induced Nausea and Vomiting | Antiemetic

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Shanghai Xianxiang Medical Technology Co., Ltd.

Active, not recruiting

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Ovarian Cancer

China
Sun Yat-sen University

Completed

Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients

Pediatric Cancer

China
Northwell Health
Staten Island University Hospital

Completed

Aprepitant for Post-operative Nausea

Postoperative Nausea

United States
Albert Einstein College of Medicine
Jacobi Medical Center

Terminated

Low Dose Aprepitant for Patients Receiving Carboplatin

Chemotherapy-induced Nausea and Vomiting

United States
Fujian Shengdi Pharmaceutical Co., Ltd.

Completed

Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy

China
Vanda Pharmaceuticals

Available

Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

Gastroparesis | Diabetic Gastroparesis

United States
Samsung Medical Center

Enrolling by invitation

Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant as PONV Prevention

Postoperative Nausea and Vomiting | Laparoscopy | Gynecologic Surgical Procedures

Korea, Republic of
University of Nebraska

Withdrawn

Comparison of Adding EMEND to PONV/PDNV Treatment Regimen

Postoperative Nausea and Vomiting

United States
Duke University
TerSera Therapeutics

Completed

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Chemo-radiation Induced Nausea and Vomiting

United States
Heron Therapeutics

Completed

Phase 2 Bunionectomy HTX-011 Administration Study

Postoperative Pain

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Malignant Neoplasm

United States, Guam
Hospital General Tlahuac

Active, not recruiting

The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting

Obesity | Nausea and Vomiting, Postoperative

Mexico
Spanish Breast Cancer Research Group
Merck Sharp & Dohme LLC

Completed

Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.

Breast Cancer

Spain
Stanford University
Epidermolysis Bullosa Research Partnership; Menlo Therapeutics

Completed

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Sun Yat-sen University

Completed

Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy (CINV)

Gastrointestinal Neoplasms | Chemotherapy-induced Nausea and Vomiting

China
Sixth Affiliated Hospital, Sun Yat-sen University

Completed

Triple Therapy for Postoperative Nausea and Vomiting in Laparoscopic Gastrointestinal Surgery

C.Surgical Procedure; Gastrointestinal

China
Sun Yat-sen University

Completed

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China

Search clinical trials for: Neurokinin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations